Pancreatic Cancer Research

ResearcherUniversity of California San DiegoNo recent work listed

Ken Fujimura

Verified by OpenAlex author ID and NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112725511; NIH RePORTER profile ID 11644130. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
7
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper, 1 grant · 2016: none · 2017: 1 paper

Papers 3

  1. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Co-author DOI 10.1158/0008-5472.can-16-2594↗
  2. Eukaryotic Translation Initiation Factor 5A (EIF5A) Regulates Pancreatic Cancer Metastasis by Modulating RhoA and Rho-associated Kinase (ROCK) Protein Expressi… Co-author DOI 10.1074/jbc.m115.687418↗
  3. A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-1031↗

Grants 1

  1. Deciphering the Role of eIF5A/PEAK1 Pathway in Pancreatic Cancer F32CA180374↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ján Strnádel · 3 shared papers, 2014–2017 · strength 0.16
  2. Richard L. Klemke · 3 shared papers, 2014–2017 · strength 0.16
  3. Michael Bouvet · 2 shared papers, 2014–2017 · strength 0.10
  4. Jonathan A. Kelber · 2 shared papers, 2014–2017 · strength 0.10
  5. Kun‐Liang Guan · 1 shared paper, 2017 · strength 0.06
  6. Cristina Angela Metildi · 1 shared paper, 2014 · strength 0.04
  7. Andrew M. Lowy · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.